CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy-Reference-Cited by-同舟云学术

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Published:2017-11-20 Issue:1 Volume:24 Page:20-28
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Fry Terry J^ORCID,Shah Nirali N,Orentas Rimas J,Stetler-Stevenson Maryalice,Yuan Constance M,Ramakrishna Sneha,Wolters Pamela,Martin Staci,Delbrook Cindy,Yates Bonnie,Shalabi Haneen,Fountaine Thomas J,Shern Jack F,Majzner Robbie G,Stroncek David F,Sabatino Marianna,Feng Yang,Dimitrov Dimiter S,Zhang Ling,Nguyen Sang,Qin Haiying,Dropulic Boro,Lee Daniel W,Mackall Crystal L^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4441.pdf

Reference58 articles.

1. Smith, M.A., Altekruse, S.F., Adamson, P.C., Reaman, G.H. & Seibel, N.L. Declining childhood and adolescent cancer mortality. Cancer 120, 2497–2506 (2014).

2. Pui, C.H. et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J. Clin. Oncol. 33, 2938–2948 (2015).

3. Rytting, M.E. et al. Augmented Berlin–Frankfurt–Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL). Cancer 120, 3660–3668 (2014).

4. Ram, R. et al. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis. Am. J. Hematol. 87, 472–478 (2012).

5. Faderl, S. et al. Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116, 1165–1176 (2010).

Cited by 1079 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we improve the successful identification of patients suitable for CAR-T cell therapy?;Expert Review of Molecular Diagnostics;2024-09-11

2. TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation;Science Advances;2024-09-06

3. Fratricide-resistant CD7-CAR T cells in T-ALL;Nature Medicine;2024-09-03

4. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

5. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09